Cemsidomide (CFT7455)

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Arms / Cohorts

Phase 1, Arm A:Cemsidomide: R/R Non-Hodgkins Lymphoma or R/R Multiple Myeloma

Accepting patients

Phase 1, Arm B1:Cemsidomide: R/R Multiple Myeloma

Accepting patients

Phase 1, Arm B2:Cemsidomide + Dexamethasone: R/R Multiple Myeloma

Accepting patients

Experimental - Phase 1, Arm C:Cemsidomide: R/R Non-Hodgkins Lymphoma

Accepting patients

Phase 2, Arm 1:Cemsidomide: R/R Multiple Myeloma

Not yet accepting

Phase 2, Arm 2:Cemsidomide + Dexamethasone: R/R Multiple Myeloma

Not yet accepting

Experimental: Phase 2, Arm 3:Cemsidomide: R/R Mantle Cell Lymphoma

Not yet accepting

Experimental: Phase 2, Arm 4:Cemsidomide: R/R Peripheral T-Cell Lymphoma

Not yet accepting

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.